2019
DOI: 10.1016/j.bioorg.2019.103250
|View full text |Cite
|
Sign up to set email alerts
|

Novel inhibitors of leukocyte transendothelial migration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
17
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 22 publications
(21 citation statements)
references
References 82 publications
3
17
0
Order By: Relevance
“…In our previous publication, we reported the screening results (the blocking of leukocyte transendothelial migration) of a series of lipophilic compounds [ 10 ]. We carefully studied the structural differences between the nonblocking (GT-77) and the completely blocking (GT-73) compounds [ 10 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In our previous publication, we reported the screening results (the blocking of leukocyte transendothelial migration) of a series of lipophilic compounds [ 10 ]. We carefully studied the structural differences between the nonblocking (GT-77) and the completely blocking (GT-73) compounds [ 10 ].…”
Section: Resultsmentioning
confidence: 99%
“…We recently developed a potent inhibitor of leukocyte transmigration from the blood to the tissues (GT-73). This compound was also able to increase the reverse transmigration of monocytes [ 10 ]. Compound GT-73, based on the scaffolding of barbituric acid, has already shown highly promising results as a drug candidate for the treatment of other inflammatory and autoimmune disorders (e.g., Crohn’s disease, multiple sclerosis, fatty liver disease, inflammatory bowel disease, and rheumatoid arthritis).…”
Section: Introductionmentioning
confidence: 99%
“… 28 MG-induced upregulation of key proteins such as ezrin, integrin β-1, Ras-related protein Rap-1b, transforming protein RhoA, Thy-1 membrane glycoprotein, and vascular cell adhesion protein 1 and downregulation of 72 kDa type IV collagenase, which are involved in leukocyte transendothelial migration, form an important step in eliciting inflammatory immune response. 29 MT1-MMP-dependent shedding of CD44 plays a key role in regulation of leukocyte adhesion to the pancreatic blood vessels and the transendothelial migration of diabetogenic, cytotoxic T cells into the islet cells. 30 This was also associated with enrichment of proteins involved in complement and coagulation cascades such as complement C3, α-2-macroglobulin, and urokinase-type plasminogen activator that were upregulated and proteins such as complement C1s subcomponent, clusterin, vitamin K-dependent protein S, and plasminogen activator inhibitor 1 were downregulated in MG-induced secretome.…”
Section: Results and Discussionmentioning
confidence: 99%
“…Myosin light chain 2 (MLC2) phosphorylation plays pivotal roles in actin/myosin motor activation to provide essential contractile forces for several cellular processes, such as cell contraction, cytokinesis, cell migration and membrane blebbing (Duan et al, 2016; Jiang et al, 2014). Leukocyte transendothelial migration is one of the most important steps in launching an inflammatory immune response and chronic inflammation can lead to devastating diseases of mice (Getter et al, 2019). The protein directly interacting with MLC2‐1 was MYH6_7 (myosin heavy chain 6/7) in the sub‐network (Figure 7b and Table 6).…”
Section: Discussionmentioning
confidence: 99%